sun pharmaceutical


Sun Pharma shares gain 4%; m-cap rises by Rs 2,384 cr

Jun 13 2018

Shares of Sun Pharmaceutical Industries today gained nearly 4 per cent after the company received EIR from the US health regulator for its Halol facility in Gujarat.

Sun Pharma says US FDA clears Halol plant

Jun 12 2018

India’s largest drugmaker Sun Pharmaceutical Industries Ltd said the US FDA cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.

USFDA for voluntary action by Sun Pharma's on Halol plant observations

Jun 08 2018

USFDA has said it found objectionable conditions at Sun Pharmaceutical Industries' Halol plant in Gujarat but did not recommend any action against the company.

Sun Pharma gets USFDA nod for plaque psoriasis drug

Mar 21 2018

Sun Pharmaceutical Industries announced that it has received approval from the US FDA for Ilumya (tildrakizumab-asmn) drug for the treatment plaque psoriasis.

China's Tasly to list biotech arm in $1 billion Hong Kong IPO

Mar 05 2018

Tasly is planning to list its biopharma unit in Hong Kong to raise about $1 billion, in what is likely to be the largest biotech float in the city this year.

Sun Pharma gets 3 observations from USFDA for Halol plant

Feb 23 2018

Sun Pharmaceutical Industries said the US health regulator has issued three observations after inspecting its Halol facility in Gujarat.

Sun Pharmaceutical scrip dips 3 percent after Q3 results

Feb 14 2018

Shares of Sun Pharmaceutical Industries fell nearly 3 percent after the company reported 75 percent dip in its consolidated net profit for the Q3 ended December 2017.

Sun Pharma Q3 profit dips 75 percent to Rs 365 crore

Feb 14 2018

Sun Pharmaceutical Industries reported 75.17 percent dip in its consolidated net profit at Rs 365.39 crore for the third quarter ended December 31, 2017-18.

Sun Pharma posts profit dive on U.S. pricing pressure

Nov 14 2017

Sun Pharmaceutical Industries reported a 59 percent plunge in second-quarter profit, hurt by generics pricing pressure in the United States.

USFDA approves Sun Pharma's generic ezetimibe tablets

Jun 13 2017

Sun Pharmaceutical Industries said that one of its wholly owned subsidiaries has received final approval from USFDA for its generic version of ezetimibe tablets.

Indian Markets


    35,513.44 33.89   (-0.10 %)

    10,760.10 11.95   (-0.11 %)

Global Markets


Stocks In News



I-T department probing acquisition of Chanda Kochhars Mumbai Residence

I-T department looking into acquisition of the residence by Deepak Kochhar

Acquisition of residence said to be linked to firms of Videocon group

Indian Express Reports


3 officials including MD & CEO RP Marathe, ED RK Gupta arrested in Pune

Arrests are in connection to fraudulent loans sanctioned to Kulkarni Developers

Outstanding exposure to DS Kulkarni Developers at Rs 94.52 Cr


RITES IPO subscribed 0.6x on day 1

Fine organic industries IPO subscribed 0.12x on day 1


SBI's B Sriram takes additional charge as MD & CEO of IDBI Bank

B Sriram is the longest serving PSB MD

B Sriram Has Experience In Managing Stressed Assets


Wins bid for Connaught Place in Delhi

Taj Group wins 33-year lease for Connaught Hotel in E-auction

Offered to share 31.8% of annual revenue earned with civic body


Have not received any notice from ED on FEMA violations


U.S. to levy tariff on Indian welded pipes

U.S. imposes anti-subsidy duties of upto 500% on welded pipes from India

China, South Korea, & Turkey to also face duties from U.S.

U.S. imported large-diameter welded pipes worth $294.7 Mn from India in 2017

U.S. International Trade Commission scheduled to make a final decision By Dec 20

twitter @BTVI